Top Markets
Coin of the day
PJSC Pharmsynthez PJSC Pharmsynthez

PJSC Pharmsynthez

LIFE
株式のランク #34084
PJSC Pharmsynthez, a pharmaceutical enterprise, focuses on the investigation,... PJSC Pharmsynthez, a pharmaceutical enterprise, focuses on the investigation, production, and supply of both proprietary (officinal) and generic active pharmaceutical ingredients across Russia and the Commonwealth of Independent States (CIS). Its portfolio of branded medicines includes Neovir, Segidrin, Fenasid, and Penkrofton, which are employed in critical therapeutic areas such as oncology, gynecology, the management of immune deficiencies, and tuberculosis. Public Joint-Stock Company Pharmsynthez has also established a collaboration with HiFiBiO Therapeutics Inks for the clinical advancement and market introduction of their SARS-CoV-2 neutralizing antibody within Russia. The company, which began operations in 1996, is headquartered in St. Petersburg, Russia.
株価
$0.02082992
最終同期: 2026-08-14
時価総額
$6.27M
変化(1日)
-3.31%
変化(1年)
-51.62%
RU
取引 PJSC Pharmsynthez (LIFE)

カテゴリー

PJSC Pharmsynthez(LIFE)の配当利回りの履歴
PJSC Pharmsynthez(銘柄コード: LIFE)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
PJSC Pharmsynthez(LIFE)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)